spacer
home > ebr > summer 2002 > preventing risk becoming a crisis
PUBLICATIONS
European Biopharmaceutical Review

Preventing Risk Becoming a Crisis

Timing has conspired to bring biopharmaceutical companies into the risk transfer arena just as the insurance market is at its least receptive to such risks. This article will highlight the driving factors and the change in management approach needed to negotiate this business hurdle, which will be new to many companies.When two independent industries both undergo radical and fundamental shifts in the make-up of their own revenue base, the results will be dramatic. Such is the current interface between the emerging biopharmaceutical industry and the retrenching insurance industry.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Howard Pearson, a Director and Head of the Science and Technology Team at The Miller Insurance Group

Howard Pearson is a Director of The Miller Insurance Group, where he heads up the science and technology team.
He is responsible for leading Millers' relationship with the biopharmaceutical industry and the UK Bio Industry Association. Howard holds a Fellowship of the Chartered Insurance Institute and is Chairman of the British Insurance Brokers Association's South East Region.

spacer
Howard Pearson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

• Collaboration to accelerate development and manufacturing of Bispecific Antibody • Merck plans to offer Phanes a full suite of products and services under its BioReliance® offering
More info >>

White Papers

Challenges of Analytical Method Transfer in the Pharmaceutical Industry

RSSL

The development and validation of suitable analytical methods is a critical part of the overall drug-development life-cycle. For the majority of products, particularly those that are clinically successful, the transfer of the analytical method between laboratories will be required. This process is designed to verify that a given laboratory is capable of performing a test method for its intended purpose. This can be performed either internally (at the same company), or, with the on-going increasing trend in outsourcing, to an external Contract Research or Development organisation (CRO or CDO).
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement